Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$77.58 - $92.26 $10,861 - $12,916
140 Added 560.0%
165 $14,000
Q1 2024

May 13, 2024

BUY
$74.84 - $88.15 $1,871 - $2,203
25 New
25 $2,000
Q2 2023

Jul 28, 2023

SELL
$69.16 - $82.11 $34,441 - $40,890
-498 Reduced 89.89%
56 $4,000
Q1 2023

May 12, 2023

SELL
$64.46 - $77.23 $23,205 - $27,802
-360 Reduced 39.39%
554 $39,000
Q3 2022

Nov 14, 2022

BUY
$56.96 - $78.09 $9,512 - $13,041
167 Added 22.36%
914 $53,000
Q2 2022

Aug 02, 2022

BUY
$64.25 - $81.25 $47,288 - $59,800
736 Added 6690.91%
747 $52,000
Q1 2021

Apr 21, 2021

BUY
$65.32 - $76.01 $718 - $836
11 New
11 $1,000
Q1 2020

May 07, 2020

SELL
$39.86 - $63.46 $2,032 - $3,236
-51 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$55.04 - $59.27 $2,807 - $3,022
51 New
51 $3,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $41.4B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.